News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
45 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21612)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Pharm Country
Celgene Takes a $411M Hit From Discontinuation of Crohn’s Disease Trials
Celgene announced back in October that it was discontinuing its GED-0301 program for Crohn’s disease and now that decision is costing the company $411M.
December 29, 2017
·
2 min read
·
Mark Terry
Biotech Bay
Investors Irate as J.P. Morgan Bars Press From Biggest Biotech Conference of the Year
Organizers said the media will be barred from the Q&A breakout sessions this year.
December 29, 2017
·
2 min read
·
Mark Terry
Drug Development
Intercept Pushes Back Key Liver Disease Trial Until Early 2018
The decision was largely expected given the time of the year and the fact the trial hasn’t yet been initiated.
December 29, 2017
·
1 min read
Biotech Bay
Apple’s Noninvasive Glucose Monitoring Could be Years Off
Apple’s research into non-invasive glucose monitoring remains ongoing.
December 29, 2017
·
1 min read
Chugai Commits $220M Into Singapore Drug Lab
The drugmaker intends to expand development of therapeutic antibodies at the lab.
December 29, 2017
·
1 min read
Biotech Bay
Bay Area’s Menlo Therapeutics Files for $98M IPO
Menlo Therapeutics filed on Thursday with the SEC to raise up to $98M in an IPO.
December 29, 2017
·
1 min read
Business
The Numbers Are In: Bay Area’s Depomed Reveals 328 Job Cuts in WARN Notice
The company’s sales department will take the brunt of the layoffs, losing 235 jobs.
December 29, 2017
·
2 min read
·
Mark Terry
Biotech Bay
Why Investors Should Dodge Gilead in 2018
Thanks to the Republican tax legislation, pharmaceutical stocks are set to continue their heady northward trajectory in 2018.
December 29, 2017
·
1 min read
Cellular Biomedicine Raises $14.5M for CAR-T Immunotherapy, Stem Cells
Cellular Biomedicine added $14.5M into its treasury through two private placements, one to key executives and the other to outside investors.
December 29, 2017
·
1 min read
Shanghai Henlius Closes $192.5M Funding for Biosimilars, Novel mAbs
Fosun contributed $50M to the fundraising, giving it a 62% majority stake in Shanghai Henlius after the offering.
December 29, 2017
·
1 min read
1 of 5
Next
